TD Cowen analysts adjusted their outlook on Biogen (NASDAQ:BIIB) shares, reducing the price target to $200 from the previous $275, while sustaining a Buy rating on the stock. The revision reflects ...
The National Labor Relations Board alleged the lender threatened and retaliated against workers in favor of unionization at a ...
The widely followed cryptocurrency analyst Benjamin Cowen is warning that Ethereum (ETH) could slide further against Bitcoin ...
President Donald Trump appointed William Cowan as acting general counsel of the National Labor Relations Board Monday evening ...
TD Cowen analyst Derrick Wood increased the price target on HubSpot Inc (NYSE: NYSE:HUBS) shares to $800 from the previous $725, while maintaining a Hold rating on the company's stock. The stock, ...
16h
TD Cowen 46th Annual Aerospace & Defense Conference February 13, 2025 8:30 AM ETCompany ParticipantsJay Malave ...
We recently published a list of 10 Important News Updates Investors Shouldn’t Miss. In this article, we are going to take a ...
TD Cowen analyst Jared Levine raised the firm’s price target on Paylocity (PCTY) to $242 from $228 and keeps a Buy rating on the shares. The ...
TD Cowen analyst John Kernan maintained a Hold rating on Under Armour (UAA – Research Report) today and set a price target of $10.00. The ...
Investing.com -- TD Cowen reinstated coverage on Tempus AI with a "Buy" rating and raised its price target to $74 after the health-tech company completed its $600 million acquisition of Ambry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback